Eli Lilly
Eli Lilly and Company develops, manufactures, and markets pharmaceutical products in the areas of diabetes, cancer, immunology, pain and neurodegeneration. Lilly Canada is the Canadian affiliate, which was founded as a collaboration between Eli Lilly and Company and Banting and Best.
Overview
Company news
- Eli Lilly to slash price of insulin drugs by 70%
- Eli Lilly commits nearly $100 million to Purdue: Money will benefit university’s pharmaceutical scholarships
- Eli Lilly and Co. DEI Office
- Late criticism ‘a slap in the face’: Some upset by Eli Lilly’s, Cummins’ statements
- Eli Lilly’s Insulin Decision Puts Others in Hot Seat; Drugmaker’s plan moves the spotlight to industry middlemen, who face a barrage of investigations
- Canadian Press Releases
Company profiles & SWOT analysis
Industry reports
- MarketLine Industry Profile: Pharmaceuticals in Canada
- MarketLine Industry Profile: Pharmaceuticals in North America
- MarketLine Industry Profile: Pharmaceuticals in Global
- Brand Name Pharmaceutical Manufacturing in the US
Trade magazines
People
- David A. Ricks – Chair and Chief Executive Officer
- Management Team
This guide is proprietary to the Rotman School and therefore we encourage all students to maintain this exclusivity. Last updated April 5, 2023.